Vanda Pharmaceuticals’ VGT-1849A gets orphan drug designation for polycythemia vera treatment

Vanda Pharmaceuticals Inc. has achieved a critical regulatory milestone with the U.S. Food and Drug Administration (FDA) granting orphan drug designation to its investigational therapy ... Read More